EUCAST Ibrexafungerp MICs and Wild-Type Upper Limits for Contemporary Danish Yeast Isolates

Ibrexafungerp is a novel triterpenoid antifungal that inhibits glucan synthase and thus fungal cell wall synthesis. We examined the in vitro activity against contemporary clinical yeast, investigated inter-laboratory and intra-laboratory variability, suggested wild-type upper-limit values (WT-UL), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Karin M., Astvad, Karen M. T., Hare, Rasmus K., Arendrup, Maiken C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605171/
https://www.ncbi.nlm.nih.gov/pubmed/36294671
http://dx.doi.org/10.3390/jof8101106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605171/
https://www.ncbi.nlm.nih.gov/pubmed/36294671
http://dx.doi.org/10.3390/jof8101106

Ejemplares similares